Every Form 4 that Apollomics Inc. (APLM) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow APLM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full APLM filings page.
Apollomics Inc. director and Chief Operating Officer Chen Yi-Kuei reported that 5,000 restricted stock units vested on September 15, 2026, corresponding to 5,000 Class A ordinary shares. Reported direct holdings after the transaction were 20,100 shares; that amount includes a 100-share adjustment for previously owned shares that had been omitted.
On September 14, 2026, Chen received an option covering 8,000 shares, with a $23.18 exercise price and a September 14, 2036 expiration date. The option vests in two installments, subject to continued service through each vesting date. The reported indirect holding through Maxpro Investment Co., Ltd. was 121,248 Class A ordinary shares.
Apollomics Inc. Chief Financial Officer Peter Kuan-How Lin reported vesting of 10,000 RSUs into 10,000 Class A ordinary shares on September 15, 2026; the derivative transaction row reports 10,000 RSUs following the transaction. On that date, 3,416 shares were delivered or withheld for payment of exercise price or tax liability at a reported $24.02 per share. Lin also received a 6,000-option grant on September 14, 2026, with a $23.18 exercise price and a September 14, 2036 expiration date. Fifty percent vests on March 14, 2027, and the remaining fifty percent on September 14, 2027, subject to continued service. The amendment corrects the option expiration date. No Rule 10b5-1 plan is reported.
Apollomics Inc. director Yen Hung Hsien’s transactions include 500 restricted stock units that vested on September 15, 2026, with 500 Class A ordinary shares acquired. On September 14, 2026, Hsien was granted 2,000 stock options with a $23.18 exercise price and a September 14, 2036 expiration date; the amendment corrects the option’s expiration date. The options vest 50% on March 14, 2027, and 50% on September 14, 2027, subject to continued service through each date.
Apollomics Inc. (APLM) reported insider equity transactions by Chief Financial Officer and director Peter Kuan-How Lin. On September 15, 2026, 10,000 Restricted Stock Units previously reported vested and were converted into 10,000 Class A Ordinary Shares, and 3,416 of those shares were delivered or withheld to cover exercise price or tax liability.
On September 14, 2026, Lin also received a grant of 6,000 stock options under the Apollomics Inc. 2023 Incentive Award Plan at an exercise price of $23.18 per share. These options vest over one year, with 50% vesting on March 14, 2027 and the remaining 50% on September 14, 2027, subject to continued service. No Rule 10b5-1 trading plan is reported for these transactions.
Apollomics Inc. (APLM) director Chen Hong-Jung reported equity compensation activity and a vesting-related share issuance. On September 15, 2026, 500 restricted stock units vested and were converted into 500 Class A Ordinary Shares, leaving 4,120 shares held directly. On September 14, 2026, Chen received a grant of stock options for 2,000 Class A Ordinary Shares at an exercise price of $23.18 per share, expiring September 14, 2036, vesting in two equal tranches on March 14, 2027 and September 14, 2027, subject to continued service. No Rule 10b5-1 trading plan is reported.
Apollomics Inc. (APLM) reported that director and Chief Operating Officer Chen Yi-Kuei had 5,000 restricted stock units vest on September 15, 2026, converting into 5,000 Class A Ordinary Shares held directly, bringing his direct holdings to 20,100 shares. On September 14, 2026 he was also granted a stock option for 8,000 shares at $23.18 per share under the 2023 Incentive Award Plan, vesting in two equal installments in 2027. In addition, 121,248 Class A Ordinary Shares are reported as held indirectly through Maxpro Investment Co., Ltd., with beneficial ownership disclaimed except to the extent of his pecuniary interest. No Rule 10b5-1 trading plan is reported.
Apollomics Inc. (APLM) director Tsai Hsien-Shu reported equity compensation activity. On September 15, 2026, 500 Restricted Stock Units vested and were settled into 500 Class A Ordinary Shares, bringing the director’s direct holdings to 2,000 Class A Ordinary Shares. On September 14, 2026, the director also received a stock option grant for 2,000 Class A Ordinary Shares at an exercise price of $23.18 per share, expiring September 14, 2036, under the Apollomics Inc. 2023 Incentive Award Plan. The option vests 50% on March 14, 2027 and 50% on September 14, 2027, subject to continued service. No Rule 10b5-1 trading plan is reported.
Apollomics Inc. (APLM) director Yen Hung Hsien reported equity compensation activity. On September 15, 2026, 500 Restricted Stock Units covering 500 Class A Ordinary Shares were exercised into 500 directly owned Class A Ordinary Shares. On September 14, 2026, the director received a grant of 2,000 stock options at an exercise price of $23.18 per share under the Apollomics Inc. 2023 Incentive Award Plan, vesting 50% on March 14, 2027 and 50% on September 14, 2027, subject to continued service.
Apollomics Inc. (APLM) reported that director Huang Ya-Chi received a grant of 2,000 stock options on September 14, 2026 under the Apollomics Inc. 2023 Incentive Award Plan, with an exercise price of $23.18 per Class A ordinary share and an expiration date of September 14, 2036.
According to the grant terms, 50% of the option vests and becomes exercisable on March 14, 2027 and the remaining 50% vests on September 14, 2027, subject to Huang’s continued service. Following this grant, Huang holds 2,000 stock options directly, and no Rule 10b5-1 trading plan is reported.
Apollomics Inc. (APLM) reported that Chief Executive Officer and director Hung-Wen Chen had 5,000 Restricted Stock Units vest on September 15, 2026, converting into 5,000 Class A Ordinary Shares and bringing his directly held Class A shares to 423,334. On September 14, 2026, he also received a grant of 8,000 stock options with an exercise price of $23.18 per share, expiring on September 14, 2036, vesting in two equal installments on March 14, 2027 and September 14, 2027, subject to continued service. In addition, 1,029,695 Class A Ordinary Shares are held indirectly through King Regent Management Limited, over which he has voting and dispositive power but disclaims beneficial ownership except to the extent of his pecuniary interest.
Apollomics Inc. (APLM) director Huang Ya-Chi reported the vesting and settlement of 500 Restricted Stock Units, each representing a contingent right to receive one Class A Ordinary Share. On August 17, 2026, these RSUs were exercised into 500 Class A Ordinary Shares at a reported price of $0.00 per share, increasing the director’s direct holdings to 1,500 Class A Ordinary Shares. Footnotes state the RSU award vests in four equal 500-share tranches on February 17, May 17, August 17, and November 17, 2026, with this transaction reflecting the August vesting.
Apollomics Inc. insider Yi-Kuei Chen, its Chief Operating Officer and director, reported an indirect purchase of 20,000 Class A ordinary shares of APLM on August 14, 2026 at $15.00 per share, acquired through a private placement transaction by Maxpro Investment Co., Ltd. Following this acquisition, indirect holdings through Maxpro Investment Co., Ltd. are reported as 121,248 shares, and a separate direct holding position of 15,000 shares is reported. The filing notes that Chen is a board member of Maxpro Investment Co., Ltd. and co-founder and managing director of Maxpro Ventures Ltd., and disclaims beneficial ownership of the Maxpro-held securities except to the extent of his pecuniary interest.
Apollomics Inc. executive Peter Kuan-How Lin, the Chief Financial Officer, purchased 26,667 Class A Ordinary Shares of APLM on August 14, 2026 at $15.00 per share. The shares were acquired pursuant to a private placement transaction referenced in a Form 6-K filed on August 12, 2026. Following this transaction, Lin directly holds 48,979 Class A Ordinary Shares.
Apollomics Inc. reported that Chief Executive Officer Hung-Wen Chen purchased a total of 536,667 Class A ordinary shares on August 14, 2026. The purchases, described as acquired pursuant to a private placement, included 166,667 shares at $12.00 per share and 103,333 shares at $15.00 per share held directly, and 266,667 shares at $15.00 per share held indirectly through King Regent Management Limited. Following the transaction, King Regent Management Limited held 1,029,695 shares, over which Mr. Chen has voting and dispositive power while disclaiming beneficial ownership beyond his pecuniary interest.
Apollomics Inc. Chief Financial Officer Peter Kuan-How Lin reported routine equity compensation activity involving restricted stock units (RSUs). On June 15, 2026, 10,000 RSUs vested into Class A Ordinary Shares, reflecting previously granted awards that vest in four 10,000-share installments.
In connection with this vesting, 3,588 Class A Ordinary Shares were disposed of to cover tax obligations, a tax-withholding disposition rather than an open-market sale. After these transactions, Lin held 22,312 Class A Ordinary Shares directly. The filing reflects compensation-related equity settlement, not a discretionary market purchase or sale.
Apollomics Inc. director and CEO Hung-Wen Chen reported equity compensation activity rather than open‑market trading. On June 15, 2026, 5,000 Restricted Stock Units vested, and he acquired 5,000 Class A Ordinary Shares at a price of $0.00 per share through a derivative exercise. Each RSU converts into one Class A Ordinary Share.
Following the transaction, Chen directly holds 148,334 Class A Ordinary Shares and has an indirect interest in 763,028 Class A Ordinary Shares held through King Regent Management Limited, where he has voting and dispositive power but disclaims beneficial ownership except for his pecuniary interest. After this vesting, 5,000 RSUs remain from the original grant, scheduled to vest on September 15, 2026.
Apollomics Inc. director CHU YI-AN acquired 500 Class A Ordinary Shares through the vesting and exercise of Restricted Stock Units (RSUs). The shares were issued at a price of $0.00 per share as part of previously granted equity awards.
Following this transaction, CHU YI-AN directly holds 1,500 Class A Ordinary Shares. The footnotes state that the initial RSU grant vested in four equal tranches of 500 shares, with three tranches (including this one on June 15, 2026) already vested and an additional 500 RSUs scheduled to vest on September 15, 2026.
Apollomics Inc. director Hong-Jung Chen exercised restricted stock units into common shares. On June 15, 2026, 500 Restricted Stock Units converted into 500 Class A Ordinary Shares at a stated price of $0.00 per share, increasing direct holdings to 3,620 Class A Ordinary Shares.
The RSUs were part of a previously disclosed grant. Footnotes explain that 500 RSUs vested on each of February 9, 2026, March 15, 2026 and June 15, 2026, and an additional 500 RSUs are scheduled to vest on September 15, 2026.
Apollomics Inc. director Tsai Hsien-Shu increased his direct equity stake through routine equity compensation. On June 15, 2026, 500 Restricted Stock Units vested, converting into 500 Class A Ordinary Shares at a price of $0.00 per share.
The RSUs were part of a prior grant under which 500 units vested on each of February 9, March 15, and June 15, 2026, with another 500 scheduled to vest on September 15, 2026. Following this transaction, Tsai directly holds 1,500 Class A Ordinary Shares and 500 remaining RSUs, reflecting standard compensation-related equity accrual rather than an open-market trade.
Apollomics Inc. director and COO Yi-Kuei Chen reported equity holdings and a routine RSU vesting. On June 15, 2026, he exercised 5,000 Restricted Stock Units at $0.00 per share, receiving 5,000 Class A Ordinary Shares, bringing his direct holdings to 15,000 shares.
He is also shown as having an indirect interest in 101,248 Class A Ordinary Shares through Maxpro Investment Co., Ltd., where he serves on the board and disclaims beneficial ownership except for his pecuniary interest. The RSUs involved in this filing were previously granted and disclosed on earlier Forms 3 and 3/A.
Apollomics Inc. director Jan Chen-Huan reported a routine equity compensation event, with 500 Restricted Stock Units vesting into 500 Class A Ordinary Shares on June 15, 2026. Each RSU represents a right to receive one Class A share. Following this vesting and related derivative exercise, Chen-Huan directly holds 1,500 Class A Ordinary Shares and 500 RSUs, with no open-market purchases or sales disclosed.
Apollomics Inc. director Huang Ya-Chi exercised restricted stock units that vested into common equity. On May 17, 2026, 500 Restricted Stock Units vested and were converted into 500 Class A Ordinary Shares at an exercise price of $0.00 per share.
Following this transaction, Huang directly holds 1,000 Class A Ordinary Shares. The RSU grant was previously disclosed, with 500 RSUs vesting on each of February 17, 2026 and May 17, 2026, and an additional 500 RSUs scheduled to vest on each of August 17, 2026 and November 17, 2026.
Apollomics Inc.'s Chief Financial Officer Peter Kuan-How Lin reported an automatic share disposition related to equity compensation. On the vesting of restricted stock units, 3,582 Class A Ordinary Shares were withheld to cover tax obligations at $15.85 per share. After this tax-withholding event, Lin directly holds 12,318 Class A Ordinary Shares. This was not an open-market sale but a routine mechanism tied to RSU vesting.